Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

FDPS antibody (AA 389-419)

FDPS Reactivity: Human WB, IHC (p) Host: Rabbit Polyclonal RB04786 unconjugated
Catalog No. ABIN389054
  • Target See all FDPS Antibodies
    FDPS (Farnesyl Diphosphate Synthase (FDPS))
    Binding Specificity
    • 15
    • 9
    • 8
    • 7
    • 7
    • 6
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 389-419
    Reactivity
    • 50
    • 28
    • 12
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Human
    Host
    • 60
    • 7
    Rabbit
    Clonality
    • 61
    • 6
    Polyclonal
    Conjugate
    • 27
    • 6
    • 6
    • 5
    • 3
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    This FDPS antibody is un-conjugated
    Application
    • 39
    • 29
    • 14
    • 13
    • 13
    • 7
    • 5
    • 4
    • 3
    • 3
    • 2
    • 1
    Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
    Purification
    This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.
    Immunogen
    This FDPS antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 389-419 amino acids from the center region of human FDPS.
    Clone
    RB04786
    Isotype
    Ig Fraction
    Top Product
    Discover our top product FDPS Primary Antibody
  • Application Notes
    WB: 1:1000. IHC-P: 1:10~50
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
    Preservative
    Sodium azide
    Precaution of Use
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    4 °C,-20 °C
    Storage Comment
    Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.
    Expiry Date
    6 months
  • Sousa, Auriola, Mönkkönen, Määttä: "Liposome encapsulated zoledronate favours M1-like behaviour in murine macrophages cultured with soluble factors from breast cancer cells." in: BMC cancer, Vol. 15, pp. 4, (2015) (PubMed).

    Todenhöfer, Hennenlotter, Kühs, Gerber, Gakis, Vogel, Aufderklamm, Merseburger, Knapp, Stenzl, Schwentner: "Altered expression of farnesyl pyrophosphate synthase in prostate cancer: evidence for a role of the mevalonate pathway in disease progression?" in: World journal of urology, Vol. 31, Issue 2, pp. 345-50, (2013) (PubMed).

    Zhang, Dai, Wang: "5-Aza-2'-deoxycytidine induced growth inhibition of leukemia cells through modulating endogenous cholesterol biosynthesis." in: Molecular & cellular proteomics : MCP, Vol. 11, Issue 7, pp. M111.016915, (2012) (PubMed).

    Ishimoto, Tachibana, Hanano, Yamasaki, Nakamura, Kawai, Urano, Tanaka, Hamakubo, Sakai, Kodama, Doi: "Sterol-regulatory-element-binding protein 2 and nuclear factor Y control human farnesyl diphosphate synthase expression and affect cell proliferation in hepatoblastoma cells." in: The Biochemical journal, Vol. 429, Issue 2, pp. 347-57, (2010) (PubMed).

    Räikkönen, Mönkkönen, Auriola, Mönkkönen: "Mevalonate pathway intermediates downregulate zoledronic acid-induced isopentenyl pyrophosphate and ATP analog formation in human breast cancer cells." in: Biochemical pharmacology, Vol. 79, Issue 5, pp. 777-83, (2010) (PubMed).

    Li, Herold, Kimmel, Müller, Rincon-Orozco, Kunzmann, Herrmann: "Reduced expression of the mevalonate pathway enzyme farnesyl pyrophosphate synthase unveils recognition of tumor cells by Vgamma9Vdelta2 T cells." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 182, Issue 12, pp. 8118-24, (2009) (PubMed).

  • Target
    FDPS (Farnesyl Diphosphate Synthase (FDPS))
    Alternative Name
    FDPS (FDPS Products)
    Synonyms
    CG12389 antibody, DmFPPS antibody, DmFPPSase antibody, DmFPS antibody, Dmel\\CG12389 antibody, FPS antibody, fpps antibody, fps antibody, l(2)k06103 antibody, v(2)k03514 antibody, NCU01175.1 antibody, 16.m00760 antibody, DDBDRAFT_0206220 antibody, DDBDRAFT_0215017 antibody, DDB_0206220 antibody, DDB_0215017 antibody, FPPS antibody, Ac2-125 antibody, (2E antibody, 6030492I17Rik antibody, AI256750 antibody, Fdpsl1 antibody, mKIAA1293 antibody, Farnesyl pyrophosphate synthase antibody, farnesyl diphosphate synthase antibody, farnesyl diphosphate synthase L homeolog antibody, farnesyl pyrophosphate synthase antibody, farnesyl pyrophosphate synthetase antibody, farnesyl-pyrophosphate synthetase antibody, FDP synthase antibody, Farnesyl pyrophosphate synthetase antibody, farnesyl diphosphate synthetase antibody, farnesyl pyrophosphate synthase 1 antibody, Fpps antibody, fdps antibody, fdps.L antibody, MGG_08649 antibody, TP03_0857 antibody, Tb09.160.4300 antibody, fpp antibody, BBOV_I000120 antibody, fps antibody, fpps antibody, FDPS antibody, Fdps antibody, fps1 antibody
    Background
    The isoprene biosynthetic pathway supply the cell with cholesterol, ubiquinone, and various nonsterol metabolites. The farnesylpyrophosphate synthetase enzyme catalyzes the formation of geranyl and farnesylpyrophosphate from isopentenylpyrophosphate and dimethylallyl pyrophosphate. Analysis of FDPS activity and protein in rat liver, accompanied by immunofluorescence and immunoelectron microscopy studies, demonstrated that FDPS is predominantly localized in peroxisomes.1 Liver tissue from patients with the peroxisomal deficiency diseases Zellweger syndrome and neonatal adrenoleukodystrophy exhibit diminished activities of FDPS and subsequent isoprenoid synthesis.
    Molecular Weight
    48275
    Gene ID
    2224
    NCBI Accession
    NP_001129293, NP_001129294, NP_001229753, NP_001229754, NP_001995
    UniProt
    P14324
    Pathways
    Regulation of Muscle Cell Differentiation
You are here:
Support